Back to All States

GlaxoSmithKline, Inc. | Company Profile, Marketing Contacts, Media Spend, Brands




Based in the United Kingdom with U.S. headquarters in Philadelphia, PA, GSK focuses on six major areas: Asthma, Diabetes, Digestive Conditions, Infections, Mental Health, and Virus Control. Pharmaceuticals, consumer healthcare products, vaccines, and drug therapies are manufactured in worldwide locations. GSK has undertaken research and development for cures to the World Health Organization's three "priority" diseases: HIV/AIDS, malaria, and tuberculosis.

Main Telephone
(919) 483-2100
Primary Address
Five Moore Drive
Research Triangle Park, NC 27709
USA

GlaxoSmithKline, Inc. Contacts

Contacts (5/146)
Name Title State
Katie W. Chief Marketing Officer - US PA
Sample of Related Brands
***********
Email: *****@*******.***
Main Phone: (215) 751-4000
Direct Phone: *** **** ***   ext: ****
Assistant Name: ** **** ***
Assistant Phone: *** **** ***
Address: Five Moore Drive

Research Triangle Park, NC
27709
USA

Lisa M. Chief Procurement Officer & Senior Vice President NJ
Matthew W. Senior Vice President, Operations - Vaccines PA
Judy S. Senior Vice President & Head, Vaccines - US PA
Ken L. Senior Vice President, Oncology PA

Media Spend

Media Spend Summary
Media Spend Channel

Related Brands

Brand Media Spend
AquaFresh *
Breathe Right Nasal Strips *******
Centrum ********
ChapStick *******
Citrucel *

Agency Roster


Brand Agency Service From To
****** ******* Digital, Social 2016 2019
****** ******** ***** ******* Media Buying, Media Planning, Production 2018 present
****** ********** ******* Creative 2019 present
****** ******* & ******* Creative 2016 present
****** ***** ********* Public Relations, Social 2016 present

See Winmo sales intelligence in action

WinmoEdge

Campaign Imminent: GSK taps creative & digital AOR amid spend increases (Score 70)


GlaxoSmithKline (GSK) announced it tapped 360i as creative and digital AOR for its Consumer Healthcare division. This includes cold and flu, digestive health and immunity. The agency will be respon...